相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The role of imaging in 2019 novel coronavirus pneumonia (COVID-19)
Wenjing Yang et al.
EUROPEAN RADIOLOGY (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)
Dae-Gyun Ahn et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
The outbreak of Coronavirus Disease 2019 (COVID-19)—An emerging global health threat
Shajeea Arshad Ali et al.
Journal of Infection and Public Health (2020)
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
Eun Kim et al.
EBIOMEDICINE (2020)
COVID-19, SARS and MERS: are they closely related?
N. Petrosillo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020
Sascha Ellington et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials
Shengli Xia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
Simon P. Graham et al.
NPJ VACCINES (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
Parismita Kalita et al.
MICROBIAL PATHOGENESIS (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
OUTRAGE OVER RUSSIA'S FAST-TRACK CORONAVIRUS VACCINE
Ewen Callaway
NATURE (2020)
Next-generation vaccine platforms for COVID-19
Debby van Riel et al.
NATURE MATERIALS (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The line starts to form for a coronavirus vaccine
Jon Cohen
SCIENCE (2020)
COVID-19 Vaccine: A comprehensive status report
Simran Preet Kaur et al.
VIRUS RESEARCH (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
Vaccination strategies to combat novel corona virus SARS-CoV-2
Satish Chandra Pandey et al.
LIFE SCIENCES (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial
Ricardo Palacios et al.
TRIALS (2020)
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
Liangwei Duan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
Tsun-Yung Kuo et al.
SCIENTIFIC REPORTS (2020)
Infections of the lung: a predictive, preventive and personalized perspective through the lens of evolution, the emergence of SARS-CoV-2 and its pathogenesis
Pankaj Ahluwalia et al.
EPMA JOURNAL (2020)
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses
Zhixing Zhu et al.
RESPIRATORY RESEARCH (2020)
The SARS-CoV-2 Vaccine Pipeline: an Overview
Wen-Hsiang Chen et al.
CURRENT TROPICAL MEDICINE REPORTS (2020)
Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection
Xiaoxiao Qi et al.
CHEMICAL COMMUNICATIONS (2020)
Age-related rhesus macaque models of COVID-19
Pin Yu et al.
ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2020)
SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat
Jun Zheng
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Robert A Feldman et al.
VACCINE (2019)
Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease
Michelle Meyer et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines
Vineet D. Menachery et al.
JOURNAL OF VIROLOGY (2018)
A Review of DNA Vaccines Against Influenza
Leo Yi Yang Lee et al.
FRONTIERS IN IMMUNOLOGY (2018)
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch et al.
FRONTIERS IN IMMUNOLOGY (2018)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
J. A. Regules et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
Norbert Pardi et al.
NATURE COMMUNICATIONS (2017)
An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+T cell responses in a mouse model
Jasdave S. Chahal et al.
SCIENTIFIC REPORTS (2017)
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease
Justin M. Richner et al.
CELL (2017)
Virus-Vectored Ebola Vaccines
I. V. Dolzhikova et al.
ACTA NATURAE (2017)
Modified mRNA Vaccines Protect against Zika Virus Infection
Justin M. Richner et al.
CELL (2017)
Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin
Michela Brazzoli et al.
JOURNAL OF VIROLOGY (2016)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
Danny N. Khalil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
Jasdave S. Chahal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains
Richard C. Condit et al.
VACCINE (2016)
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
Anurodh Shankar Agrawal et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine
Karuppiah Muthumani et al.
NPJ VACCINES (2016)
Recent Advances in Subunit Vaccine Carriers
Abhishek Vartak et al.
VACCINES (2016)
Chimeric Antigen Receptor Engineering: A Right Step in the Evolution of Adoptive Cellular Immunotherapy
Jose A. Figueroa et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2015)
Severe Acute Respiratory Syndrome Coronaviruses with Mutations in the E Protein Are Attenuated and Promising Vaccine Candidates
Jose A. Regla-Nava et al.
JOURNAL OF VIROLOGY (2015)
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial
Hannah Kibuuka et al.
LANCET (2015)
Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults
Michelle C. Crank et al.
PLOS ONE (2015)
DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial
Julie E. Ledgerwood et al.
PLOS ONE (2015)
Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
Jian Tang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
Uzma N. Sarwar et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Adenovirus: The First Effective In Vivo Gene Delivery Vector
Ronald G. Crystal
HUMAN GENE THERAPY (2014)
Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein
Nicolas Escriou et al.
VIROLOGY (2014)
Development of replication-competent viral vectors for HIV vaccine delivery
Christopher L. Parks et al.
CURRENT OPINION IN HIV AND AIDS (2013)
Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
Armin Hekele et al.
EMERGING MICROBES & INFECTIONS (2013)
Synthetic DNA vaccines: improved vaccine potency by electroporation anc co-delivered genetic adjuvants
Seleeke Flingai et al.
FRONTIERS IN IMMUNOLOGY (2013)
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
Benjamin Petsch et al.
NATURE BIOTECHNOLOGY (2012)
A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease
Rachel L. Graham et al.
NATURE MEDICINE (2012)
DNA vaccines: an historical perspective and view to the future
Margaret A. Liu
IMMUNOLOGICAL REVIEWS (2011)
Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease
Jason Netland et al.
VIROLOGY (2010)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine
Noton Kumar Dutta et al.
IMMUNOLOGY LETTERS (2008)
Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus
Peggy A. Lalor et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brain
Weidong Xiong et al.
MOLECULAR THERAPY (2008)
Vaxfectin™-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge
Gretchen S. Jimenez et al.
HUMAN VACCINES (2007)
A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo
Marta L. DeDiego et al.
JOURNAL OF VIROLOGY (2007)
Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: Implications for a subunit vaccine
Alexander N. Zakhartchouk et al.
VACCINE (2007)
Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain
Fang Li et al.
JOURNAL OF VIROLOGY (2006)
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
Nancy J. Sullivan et al.
PLOS MEDICINE (2006)
A convenient plasmid system for construction of helper-dependent adenoviral vectors and its application for analysis of the breast-cancer-specific mammaglobin promoter
CX Shi et al.
JOURNAL OF GENE MEDICINE (2006)
Preclinical and clinical safety studies on DNA vaccines
Johanna A. C. Schalk et al.
HUMAN VACCINES (2006)
Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses
WD Xiong et al.
JOURNAL OF VIROLOGY (2006)
Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
SU Kapadia et al.
VIROLOGY (2005)
Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines
AN Zakhartchouk et al.
VACCINE (2005)
Construction of a eukaryotic expression plasmid encoding partial S gene fragments of the SARS-CoV and its potential utility as a DNA vaccine
HX He et al.
DNA AND CELL BIOLOGY (2005)
Elicitation of immunity in mice after immunization with the S2 subunit of the severe acute respiratory syndrome coronavirus
YJ Guo et al.
DNA AND CELL BIOLOGY (2005)
Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain
CH Zhanga et al.
VACCINE (2005)
Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine
P Zhao et al.
VIROLOGY (2005)
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
A Bukreyev et al.
LANCET (2004)
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
YX He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The injection of plasmid DNA in mouse muscle results in lifelong persistence of DNA, gene expression, and humoral response
G Armengol et al.
MOLECULAR BIOTECHNOLOGY (2004)
分享论文
